Process of care indicators of PCI
| Overall | Stable CAD | ACS | |||||
|---|---|---|---|---|---|---|---|
| Quality indicators | Number of eligible patients (% treated) | Hospital range (%) | Number of eligible patients (% treated) | Hospital range (%) | Number of eligible patients (% treated) | Hospital range (%) | p Value* |
| Preprocedure process of care | |||||||
| Aspirin before PCI | 3020 (89.0%) | 14.1–100 | 539 (95.9%) | 8.3–100 | 2481 (87.5%) | 14.5–100 | <0.001 |
| Renal function assessment before PCI | 3011 (94.5%) | 84.0–100 | 542 (96.7%) | 84.6–100 | 2469 (94.0%) | 80.0–100 | 0.012 |
| Postprocedural process of care | |||||||
| Cardiac biomarker measurement after PCI | 2919 (90.5%) | 54.4–100 | 533 (86.7%) | 33.3–100 | 2386 (91.4%) | 61.4–100 | <0.001 |
| Processes of care at hospital discharge | |||||||
| Aspirin | 2968 (98.7%) | 93.5–100 | 536 (99.4%) | 81.8–100 | 2432 (98.5%) | 91.8–100 | 0.08 |
| >1 month dual antiplatelet therapy for BMS | 1698 (97.0%) | 89.1–100 | 225 (98.7%) | 94.6–100 | 1473 (96.7%) | 88.9–100 | 0.115 |
| >12 month dual antiplatelet therapy for DES | 1065 (95.1%) | 76.1–100 | 256 (97.3%) | 75.0–100 | 809 (94.4%) | 75.0–100 | 0.067 |
| Statin therapy | 2963 (94.9%) | 84.1–100 | 533 (90.1%) | 74.1–100 | 2430 (96.0%) | 82.0–100 | <0.001 |
| Smoking cessation advice/counselling/therapy | 1438 (41.9%) | 7.7–86.3 | 251 (17.9%) | 0–100 | 1187 (46.9%) | 13.4–86.1 | <0.001 |
| Mean Composite Adherence Score (mean % ±SD)† | 89%±14% | 87%±14% | 90%±14% | 0.003 | |||
*p Value compares characteristics between patients with stable CAD and ACS.
†Individual composite adherence score was calculated as the total number of indicators performed divided by the total number of eligible indicators.
ACS, acute coronary syndrome; BMS, bare-metal stent; CAD, coronary artery disease; DES, drug-eluting stent; PCI, percutaneous coronary intervention.